Population
Human cardiac sodium channel (hH1) expressing the R1623Q mutation
Comparison
Electrophysiological characterization using… vs Autosomal dominant LQT3 mutations
Design
Preclinical
Authors
Loading...
Lidocaine may correct R1623Q sodium defects in models; leaves open clinical translation and patient benefit.
The R1623Q mutation causes a severe long-QT phenotype through unique inactivation gating defects that prolong sodium current decay, which can be reversed by lidocaine.
Kambouris et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: